Copyright Reports & Markets. All rights reserved.

Global Primary Antibodies Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Primary Antibodies Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Primary Antibodies Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Primary Antibodies Market Size Growth Rate by Type
    • 1.4.2 Polyclonal
    • 1.4.3 Monoclonal
  • 1.5 Market by Application
    • 1.5.1 Global Primary Antibodies Market Size Growth Rate by Application
    • 1.5.2 ELISA
    • 1.5.3 Western Blot
    • 1.5.4 Immunostaining
    • 1.5.5 Immunohistochemistry
    • 1.5.6 Immunocytochemistry
    • 1.5.7 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Primary Antibodies Market Size, Estimates and Forecasts
    • 2.1.1 Global Primary Antibodies Revenue 2015-2026
    • 2.1.2 Global Primary Antibodies Sales 2015-2026
  • 2.2 Global Primary Antibodies, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Primary Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Primary Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Primary Antibodies Competitor Landscape by Players

  • 3.1 Primary Antibodies Sales by Manufacturers
    • 3.1.1 Primary Antibodies Sales by Manufacturers (2015-2020)
    • 3.1.2 Primary Antibodies Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Primary Antibodies Revenue by Manufacturers
    • 3.2.1 Primary Antibodies Revenue by Manufacturers (2015-2020)
    • 3.2.2 Primary Antibodies Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Primary Antibodies Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Primary Antibodies Revenue in 2019
    • 3.2.5 Global Primary Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Primary Antibodies Price by Manufacturers
  • 3.4 Primary Antibodies Manufacturing Base Distribution, Product Types
    • 3.4.1 Primary Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Primary Antibodies Product Type
    • 3.4.3 Date of International Manufacturers Enter into Primary Antibodies Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Primary Antibodies Market Size by Type (2015-2020)
    • 4.1.1 Global Primary Antibodies Sales by Type (2015-2020)
    • 4.1.2 Global Primary Antibodies Revenue by Type (2015-2020)
    • 4.1.3 Primary Antibodies Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Primary Antibodies Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Primary Antibodies Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Primary Antibodies Revenue Forecast by Type (2021-2026)
    • 4.2.3 Primary Antibodies Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Primary Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Primary Antibodies Market Size by Application (2015-2020)
    • 5.1.1 Global Primary Antibodies Sales by Application (2015-2020)
    • 5.1.2 Global Primary Antibodies Revenue by Application (2015-2020)
    • 5.1.3 Primary Antibodies Price by Application (2015-2020)
  • 5.2 Primary Antibodies Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Primary Antibodies Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Primary Antibodies Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Primary Antibodies Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Primary Antibodies by Country
    • 6.1.1 North America Primary Antibodies Sales by Country
    • 6.1.2 North America Primary Antibodies Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Primary Antibodies Market Facts & Figures by Type
  • 6.3 North America Primary Antibodies Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Primary Antibodies by Country
    • 7.1.1 Europe Primary Antibodies Sales by Country
    • 7.1.2 Europe Primary Antibodies Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Primary Antibodies Market Facts & Figures by Type
  • 7.3 Europe Primary Antibodies Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Primary Antibodies by Region
    • 8.1.1 Asia Pacific Primary Antibodies Sales by Region
    • 8.1.2 Asia Pacific Primary Antibodies Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Primary Antibodies Market Facts & Figures by Type
  • 8.3 Asia Pacific Primary Antibodies Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Primary Antibodies by Country
    • 9.1.1 Latin America Primary Antibodies Sales by Country
    • 9.1.2 Latin America Primary Antibodies Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Primary Antibodies Market Facts & Figures by Type
  • 9.3 Central & South America Primary Antibodies Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Primary Antibodies by Country
    • 10.1.1 Middle East and Africa Primary Antibodies Sales by Country
    • 10.1.2 Middle East and Africa Primary Antibodies Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Primary Antibodies Market Facts & Figures by Type
  • 10.3 Middle East and Africa Primary Antibodies Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abcam
    • 11.1.1 Abcam Corporation Information
    • 11.1.2 Abcam Description and Business Overview
    • 11.1.3 Abcam Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abcam Primary Antibodies Products Offered
    • 11.1.5 Abcam Related Developments
  • 11.2 BD
    • 11.2.1 BD Corporation Information
    • 11.2.2 BD Description and Business Overview
    • 11.2.3 BD Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 BD Primary Antibodies Products Offered
    • 11.2.5 BD Related Developments
  • 11.3 Santa Cruz Biotechnology
    • 11.3.1 Santa Cruz Biotechnology Corporation Information
    • 11.3.2 Santa Cruz Biotechnology Description and Business Overview
    • 11.3.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Santa Cruz Biotechnology Primary Antibodies Products Offered
    • 11.3.5 Santa Cruz Biotechnology Related Developments
  • 11.4 Sigma Aldrich Corporation
    • 11.4.1 Sigma Aldrich Corporation Corporation Information
    • 11.4.2 Sigma Aldrich Corporation Description and Business Overview
    • 11.4.3 Sigma Aldrich Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sigma Aldrich Corporation Primary Antibodies Products Offered
    • 11.4.5 Sigma Aldrich Corporation Related Developments
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Corporation Information
    • 11.5.2 Thermo Fisher Scientific Description and Business Overview
    • 11.5.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Thermo Fisher Scientific Primary Antibodies Products Offered
    • 11.5.5 Thermo Fisher Scientific Related Developments
  • 11.6 Bio-Rad
    • 11.6.1 Bio-Rad Corporation Information
    • 11.6.2 Bio-Rad Description and Business Overview
    • 11.6.3 Bio-Rad Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Bio-Rad Primary Antibodies Products Offered
    • 11.6.5 Bio-Rad Related Developments
  • 11.7 R&D Systems
    • 11.7.1 R&D Systems Corporation Information
    • 11.7.2 R&D Systems Description and Business Overview
    • 11.7.3 R&D Systems Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 R&D Systems Primary Antibodies Products Offered
    • 11.7.5 R&D Systems Related Developments
  • 11.8 MBL
    • 11.8.1 MBL Corporation Information
    • 11.8.2 MBL Description and Business Overview
    • 11.8.3 MBL Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 MBL Primary Antibodies Products Offered
    • 11.8.5 MBL Related Developments
  • 11.9 CST
    • 11.9.1 CST Corporation Information
    • 11.9.2 CST Description and Business Overview
    • 11.9.3 CST Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 CST Primary Antibodies Products Offered
    • 11.9.5 CST Related Developments
  • 11.10 Merk
    • 11.10.1 Merk Corporation Information
    • 11.10.2 Merk Description and Business Overview
    • 11.10.3 Merk Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Merk Primary Antibodies Products Offered
    • 11.10.5 Merk Related Developments
  • 11.1 Abcam
    • 11.1.1 Abcam Corporation Information
    • 11.1.2 Abcam Description and Business Overview
    • 11.1.3 Abcam Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abcam Primary Antibodies Products Offered
    • 11.1.5 Abcam Related Developments
  • 11.12 PeproTech
    • 11.12.1 PeproTech Corporation Information
    • 11.12.2 PeproTech Description and Business Overview
    • 11.12.3 PeproTech Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 PeproTech Products Offered
    • 11.12.5 PeproTech Related Developments
  • 11.13 Cayman
    • 11.13.1 Cayman Corporation Information
    • 11.13.2 Cayman Description and Business Overview
    • 11.13.3 Cayman Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Cayman Products Offered
    • 11.13.5 Cayman Related Developments
  • 11.14 AbMax Biotechnology
    • 11.14.1 AbMax Biotechnology Corporation Information
    • 11.14.2 AbMax Biotechnology Description and Business Overview
    • 11.14.3 AbMax Biotechnology Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 AbMax Biotechnology Products Offered
    • 11.14.5 AbMax Biotechnology Related Developments
  • 11.15 MABTech
    • 11.15.1 MABTech Corporation Information
    • 11.15.2 MABTech Description and Business Overview
    • 11.15.3 MABTech Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 MABTech Products Offered
    • 11.15.5 MABTech Related Developments
  • 11.16 KPL
    • 11.16.1 KPL Corporation Information
    • 11.16.2 KPL Description and Business Overview
    • 11.16.3 KPL Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 KPL Products Offered
    • 11.16.5 KPL Related Developments
  • 11.17 Abnova
    • 11.17.1 Abnova Corporation Information
    • 11.17.2 Abnova Description and Business Overview
    • 11.17.3 Abnova Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Abnova Products Offered
    • 11.17.5 Abnova Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Primary Antibodies Market Estimates and Projections by Region
    • 12.1.1 Global Primary Antibodies Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Primary Antibodies Revenue Forecast by Regions 2021-2026
  • 12.2 North America Primary Antibodies Market Size Forecast (2021-2026)
    • 12.2.1 North America: Primary Antibodies Sales Forecast (2021-2026)
    • 12.2.2 North America: Primary Antibodies Revenue Forecast (2021-2026)
    • 12.2.3 North America: Primary Antibodies Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Primary Antibodies Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Primary Antibodies Sales Forecast (2021-2026)
    • 12.3.2 Europe: Primary Antibodies Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Primary Antibodies Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Primary Antibodies Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Primary Antibodies Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Primary Antibodies Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Primary Antibodies Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Primary Antibodies Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Primary Antibodies Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Primary Antibodies Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Primary Antibodies Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Primary Antibodies Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Primary Antibodies Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Primary Antibodies Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Primary Antibodies Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Primary Antibodies Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Primary Antibodies Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Primary Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Primary Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Primary Antibodies market is segmented into
    Polyclonal
    Monoclonal

    Segment by Application, the Primary Antibodies market is segmented into
    ELISA
    Western Blot
    Immunostaining
    Immunohistochemistry
    Immunocytochemistry
    Other

    Regional and Country-level Analysis
    The Primary Antibodies market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Primary Antibodies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Primary Antibodies Market Share Analysis
    Primary Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Primary Antibodies business, the date to enter into the Primary Antibodies market, Primary Antibodies product introduction, recent developments, etc.

    The major vendors covered:
    Abcam
    BD
    Santa Cruz Biotechnology
    Sigma Aldrich Corporation
    Thermo Fisher Scientific
    Bio-Rad
    R&D Systems
    MBL
    CST
    Merk
    Novus Biologicals
    PeproTech
    Cayman
    AbMax Biotechnology
    MABTech
    KPL
    Abnova

    Buy now